Document Detail


Otomycosis in Turkey: predisposing factors, aetiology and therapy.
MedLine Citation:
PMID:  12590854     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Otomycosis usually requires long-term treatment and tends to recur. This study was performed on 87 patients with the clinical diagnosis of otomycosis and 20 controls in order to determine the pathogenic agents, predisposing factors and a cost-effective treatment. The predisposing factors included wearing head clothes (74.7 per cent), presence of dermatomycoses (34.5 per cent) and swimming (27.6 per cent). The most common pathogenic fungus was Aspergillus niger (44.8 per cent) in the otomycosis group. The only isolate was Candida albicans in the control group (2.5 per cent). We concluded that administration of four per cent boric acid solution in alcohol and frequent suction cleaning of the ear canal might be a cost-effective treatment for otomycosis since 77 per cent of the patients were treated effectively this way. Eighty per cent of the resistant cases had mixed fungal-bacterial infections, and 50 per cent of them had dermatomycoses. These resistant cases were treated by administration of tioconazole ointment.
Authors:
K Murat Ozcan; Muge Ozcan; Aydin Karaarslan; Filiz Karaarslan
Related Documents :
922314 - The finding of thrombus at carotid endarterectomy and its relationship to the timing of...
438244 - Recurrent anterior dislocation of the shoulder. results after the bankart and putti-pla...
1167234 - Postoperative ventilatory performance: dependence upon surgical incision.
2015484 - Effects of cardiac surgery and intraoperative hypothermia on energy expenditure as meas...
16001374 - Suspension made with amniotic membrane: clinical trial.
10630494 - Effect of intravenous clarithromycin on interdigestive gastroduodenal motility of patie...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  The Journal of laryngology and otology     Volume:  117     ISSN:  0022-2151     ISO Abbreviation:  J Laryngol Otol     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2003-02-19     Completed Date:  2003-03-24     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8706896     Medline TA:  J Laryngol Otol     Country:  England    
Other Details:
Languages:  eng     Pagination:  39-42     Citation Subset:  AIM; IM    
Affiliation:
Department of Otolaryngology, Ankara Numune Education and Research Hospital, Ankara, Turkey. mugeozcan@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Antifungal Agents / therapeutic use
Bacterial Infections / microbiology
Boric Acids / therapeutic use
Ear Diseases / drug therapy,  microbiology*
Female
Humans
Male
Middle Aged
Mycoses / drug therapy,  microbiology*
Risk Factors
Turkey
Chemical
Reg. No./Substance:
0/Antifungal Agents; 0/Boric Acids; 11113-50-1/boric acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  External auditory canal duplication anomalies associated with congenital aural atresia.
Next Document:  Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, ...